Free online reference management for clinicians and scientists

Sign up now

Recent "antibodies" articles

  • These articles and links have been posted by Connotea users using the tag "antibodies".
  • To add to this collection, or to start your own library:

Learn more

Watch a short video (2m 41s)

EXPORT LIST RSS ?
Bookmarks matching tag antibodies
Geographical data are available for 1 of these links.
 
Number of articles per page:
10 | 25 | 50 | 100
 
Target-seeking Antibodies For Cancer Therapy
Sudipta Das
Cancer Information & Education, (21 Jul 2008)
The chemist Dario Neri has carried out research for more than 15 years to find antibodies suitable as drug delivery vehicles for selective anti-cancer treatment.
 
Immunity -- Human Neutrophil Fcγ Receptors Initiate and Play Specialized Nonredundant Roles in Antibody-Mediated Inflammatory Diseases
www.immunity.com
Inflammation mediated by antibody-antigen complexes contributes to autoimmune diseases. Mice deficient in the common Fcγ-chain are protected from IgG-mediated glomerulonephritis and the reverse passive Arthus (RPA) reaction and FcR-bearing macrophages, and mast cells have been assigned primary roles in these processes. Here we demonstrate that neutrophil-selective transgenic expression of the two uniquely human neutrophil Fc gamma receptors (FcγRs), FcγRIIA and FcγRIIIB, in Fcγ-chain-deficient mice restored susceptibility to progressive glomerulonephritis and the cutaneous RPA reaction. FcγRIIIB and FcγRIIA mediated neutrophil accumulation, whereas FcγRIIA alone promoted organ injury. In a model of soluble immune complexes deposited within the vasculature, FcγRIIIB was responsible for neutrophil slow rolling and adhesion whereas in the cremaster RPA, induced by both vascular and tissue soluble immune complexes, FcγRIIA predominated. Thus, human FcγRs on neutrophils serve as molecular links between antibody and immunological disease, with FcγRIIA promoting tissue injury and FcγRIIIB and FcγRIIA displaying specialized context-dependent functions in neutrophil recruitment.
 
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
William Pao et al.
PLoS Medicine 2 (1), e17 (01 Jan 2005)
 
Structural evidence for substrate strain in antibody catalysis
Jun Yin et al.
Proceedings of the National Academy of Sciences of the United States of America 100 (3), 856-61 (04 Feb 2003)
 
Directed evolution of high-affinity antibody mimics using mRNA display
Lihui Xu et al.
Chemistry & biology. 9 (8), 933-42 (Aug 2002)
 
Bringing biological solutions to chemical problems
P G Schultz
Proceedings of the National Academy of Sciences of the United States of America 95 (25), 14590-1 (08 Dec 1998)
 
The interplay between chemistry and biology in the design of enzymatic catalysts
P G Schultz
Science (New York, N.Y.) 240 (4851), 426-33 (22 Apr 1988)
 
Cardiotoxicity of cytotoxic drugs
Kirsten J M Schimmel et al.
Cancer treatment reviews 30 (2), 181-91 (Apr 2004)
 
Recent advances in catalytic antibodies
T S Scanlon and P G Schultz
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 332 (1263), 157-64 (29 May 1991)
 
Immunological origins of binding and catalysis in a Diels-Alderase antibody
F E Romesberg et al.
Science (New York, N.Y.) 279 (5358), 1929-33 (20 Mar 1998)

<< Prev 0      Showing entries 1 to 10 of 357 total      Next 10 >>